Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Innovate Corp (VATE)

Innovate Corp (VATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 47,882
  • Shares Outstanding, K 79,235
  • Annual Sales, $ 1,423 M
  • Annual Income, $ -35,200 K
  • 60-Month Beta 2.10
  • Price/Sales 0.03
  • Price/Cash Flow 6.26
  • Price/Book N/A
Trade VATE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.47
  • Most Recent Earnings $-0.12 on 03/04/24
  • Latest Earnings Date 05/08/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 8.500 on 08/28/13
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 562.41% ( +23.55%)
  • Historical Volatility 96.31%
  • IV Percentile 98%
  • IV Rank 73.94%
  • IV High 745.57% on 02/27/24
  • IV Low 42.80% on 09/13/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 699
  • Open Int (30-Day) 605

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5745 +1.43%
on 04/18/24
0.7614 -23.47%
on 03/25/24
-0.0666 (-10.26%)
since 03/19/24
3-Month
0.5685 +2.50%
on 03/15/24
1.0800 -46.05%
on 01/22/24
-0.4773 (-45.03%)
since 01/19/24
52-Week
0.5685 +2.50%
on 03/15/24
3.0100 -80.64%
on 04/20/23
-2.3773 (-80.31%)
since 04/19/23

Most Recent Stories

More News
AIMIA APPOINTS SUZI HERBST AS CHIEF OPERATING OFFICER

/CNW/ - Aimia Inc. (TSX: AIM) ("Aimia"), a holding company focused on long-term global investments, announced today that it has appointed Suzanne ("Suzi")...

VATE : 0.6058 (+0.25%)
AIM.TO : 2.42 (+5.22%)
MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

/CNW/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment of Dr....

CI : 352.39 (+1.04%)
VATE : 0.6058 (+0.25%)
MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer

/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the appointment...

VATE : 0.6058 (+0.25%)
Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary

Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President,...

VATE : 0.6058 (+0.25%)
PSEC : 5.41 (-1.10%)
CTLT : 55.48 (-0.57%)
MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System

/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...

VATE : 0.6058 (+0.25%)
MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Development of Transdermal GFR Measurement System

/CNW/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...

VATE : 0.6058 (+0.25%)
INNOVATE Corp. Announces Second Quarter 2022 Results

- Infrastructure: DBM Global delivers revenue of $382.1 million in the second quarter driven by continued strength at Banker Steel and robust demand in the...

VATE : 0.6058 (+0.25%)
INNOVATE Corp. Announces Appointment of Amy Wilkinson to the Board of Directors

NEW YORK, Aug. 02, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), today announced the appointment of Amy Wilkinson...

VATE : 0.6058 (+0.25%)
INNOVATE Corp. to Report Second Quarter 2022 Results on August 3

NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial...

VATE : 0.6058 (+0.25%)
INNOVATE Corp. Announces Appointment of Brian Goldstein to the Board of Directors

NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), today announced the appointment of Brian Goldstein...

VATE : 0.6058 (+0.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

INNOVATE Corp. is a portfolio of assets in areas of infrastructure, life sciences and spectrum. INNOVATE Corp., formerly known as HC2 Holdings Inc., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 0.6722
2nd Resistance Point 0.6467
1st Resistance Point 0.6255
Last Price 0.6058
1st Support Level 0.5788
2nd Support Level 0.5533
3rd Support Level 0.5321

See More

52-Week High 3.0100
Fibonacci 61.8% 2.0773
Fibonacci 50% 1.7893
Fibonacci 38.2% 1.5012
Last Price 0.6058
52-Week Low 0.5685

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar